Prospect Wallet ^Company

NEU-723 is a highly potent and selective leucine-rich repeat kinase 2 (LRRK2) inhibitor First-of-its-kind companion diagnostic paired with NEU-723 will enable selection of patients likely to respond to therapy SOUTH SAN FRANCISCO, Calif. February 7, 2023 Neuron23 Inc., a clinical-stage biotechnology company focused on developing precision medicines for genetically defined ...